Lytic cycle: A defining process in oncolytic virotherapy
From MaRDI portal
(Redirected from Publication:380125)
Recommendations
- Mathematical analysis for oncolytic virotherapy
- Spatial model for oncolytic virotherapy with lytic cycle delay
- The replicability of oncolytic virus: defining conditions in tumor virotherapy
- Hopf bifurcation in oncolytic therapeutic modeling: viruses as anti-tumor means with viral lytic cycle
- Analysis of a multiple delays model for treatment of cancer with oncolytic virotherapy
Cited in
(22)- The role of the innate immune system in oncolytic virotherapy
- The replicability of oncolytic virus: defining conditions in tumor virotherapy
- Hopf bifurcation analysis and optimal control of treatment in a delayed oncolytic virus dynamics
- Enhancement of chemotherapy using oncolytic virotherapy: mathematical and optimal control analysis
- Spatial model for oncolytic virotherapy with lytic cycle delay
- Mathematical analysis of a mathematical model of chemovirotherapy: effect of drug infusion method
- Modeling the virus-induced tumor-specific immune response with delay in tumor virotherapy
- A delayed fractional-order tumor virotherapy model: stability and Hopf bifurcation
- Analysis of a delayed and diffusive oncolytic M1 virotherapy model with immune response
- Ultimate tumor dynamics and eradication using oncolytic virotherapy
- Global dynamics of reaction-diffusion oncolytic M1 virotherapy with immune response
- Analysis of a multiple delays model for treatment of cancer with oncolytic virotherapy
- Backward Hopf bifurcation in a mathematical model for oncolytic virotherapy with the infection delay and innate immune effects
- Hopf bifurcation in oncolytic therapeutic modeling: viruses as anti-tumor means with viral lytic cycle
- Dynamical analysis of a melanoma model with immune response
- Dynamics of immunotherapy antitumor models with impulsive control strategy
- On a three-dimensional and two four-dimensional oncolytic viro-therapy models
- A general non-local delay model on oncolytic virus therapy
- Oscillations in a spatial oncolytic virus model
- Optimal control of tumor-lymphatic model with immuno-chemotherapy
- Hopf bifurcation and normal form in a delayed oncolytic model
- Modeling oncolytic virus therapy with distributed delay and nonlocal diffusion
This page was built for publication: Lytic cycle: A defining process in oncolytic virotherapy
Report a bug (only for logged in users!)Click here to report a bug for this page (MaRDI item Q380125)